Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Colon Targeting Drug Delivery Market Size Changed, over the years?
The market size for colon-targeted drug delivery has seen robust growth in the past few years. The market is predicted to expand from $1.39 billion in 2024 to $1.51 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. This growth during the historical period is due to factors such as the rising incidence of colorectal diseases, an increased emphasis on local drug delivery, the requirements for better patient adherence, and the rise of biologics and peptides.
How Much Will the Colon Targeting Drug Delivery Market Be Worth in 2029?
The market size of colon-targeting drug delivery is predicted to undergo substantial growth in the following years, ballooning to $2.07 billion by 2029 with a compound annual growth rate of 8.3%. The expected growth within this forecast period can be associated to the progression of stimuli-responsive and nanotech-based delivery systems, the expansion of contract research and manufacturing services, the provision of incentives and faster approval channels by regulatory authorities, and the targeted distribution of biologics and biosimilars. Noteworthy trends during the forecast period consist of advancements in pH-responsive, the integration of personalized medicine, the application of Artificial Intelligence and digital tools in formulating designs, and a heightened emphasis on oral colon delivery.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24194&type=smp
Which is the Largest Company in the Colon Targeting Drug Delivery Market?
Major companies operating in the colon targeting drug delivery market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Lonza Pharma AG, Ferring Pharmaceuticals Company Limited, Salix Pharmaceuticals Ltd., Tillotts Pharma AG, BDD Pharma Ltd., Tharimmune Inc.
What Are the Main Market Drivers in the Colon Targeting Drug Delivery Industry?
The surge in gastrointestinal ailments is anticipated to fuel the expansion of the colon targeting drug delivery market in the future. These ailments are disorders that impact the digestive track, including the stomach, intestines, and the attached organs. Unhealthy dietary practices, such as overeating processed foods and inadequate fiber consumption, are leading to a rise in cases causing disruptions to gut health and digestion. Colon targeting drug delivery system is employed in these diseases to guarantee accurate drug discharge at the site of swelling or infection, thus increasing the therapeutic efficacy and minimising systemic side effects. For instance, Crohn’s and Colitis Canada, a charitable organization, suggested in June 2023 that the count of people suffering from inflammatory bowel disease is predicted to jump from 322,600 in 2023 (comprising 0.8% of the population) to 470,000 by 2035 (1.1% of the population). Consequently, the mounting prevalence of gastrointestinal diseases is stimulating the growth of the colon targeting drug delivery market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24194&type=smp
How Is the Colon Targeting Drug Delivery Market Segments Structured?
The colon targeting drug delivery market covered in this report is segmented –
1) By Dosage Form: Tablets, Capsules, Microspheres, Nanoparticles, Other Dosage Form
2) By Technology: pH-Sensitive Systems, Time-Dependent Systems, Microbially Triggered Systems, Pressure-Controlled Systems, Other Technologies
3) By Application: Inflammatory Bowel Disease, Colorectal Cancer, Infectious Diseases, Other Application
4) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Tablets: Extended-Release Tablets, Enteric-Coated Tablets, Osmotic Pump Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Enteric-Coated Capsules
3) By Microspheres: Polymeric Microspheres, Biodegradable Microspheres, Non-biodegradable Microspheres
4) By Nanoparticles: Polymeric Nanoparticles, Solid Lipid Nanoparticles, Dendrimers, Lipid-Polymer Hybrid Nanoparticles
4) By Other Dosage Form: Films, Injections, Hydrogels, Suppositories
What Strategic Trends Are Transforming the Colon Targeting Drug Delivery Market?
Key players in the colon targeting drug delivery market are striving to develop novel drug delivery methods, including functional oral dosage forms, to enhance drug targeting, increase therapeutic effectiveness, and lessen adverse reactions. Functional oral dosage forms are utilized in colon-targeted drug delivery to safeguard active pharmaceutical ingredients from degradation in the upper gastrointestinal tract and ensure their regulated release specifically within the colon. For example, in September 2024, Evonik Industries AG, a German specialty chemicals firm, introduced EUDRACAP Functional, a ready-to-use capsule technology for targeted delivery of oral drugs to the colon. Utilizing pH-sensitive polymers, this advanced solution ensures an accurate release that occurs only at certain intestinal pH levels, ensuring the API is transported intact to the colon. By facilitating the oral delivery of intricate APIs, such as peptides and probiotics, EUDRACAP Functional aids in developing patient-friendly treatments and broadens the options for accurately treating chronic gastrointestinal disorders with diminished systemic exposure.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/colon-targeting-drug-delivery-global-market-report
Which Global Regions Offer the Highest Growth in the Colon Targeting Drug Delivery Market?
North America was the largest region in the colon targeting drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colon targeting drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24194&type=smp
This Report Delivers Insight On:
1. How big is the colon targeting drug delivery market, and how is it changing globally?
2. Who are the major companies in the colon targeting drug delivery market, and how are they performing?
3. What are the key opportunities and risks in the colon targeting drug delivery market right now?
4. Which products or customer segments are growing the most in the colon targeting drug delivery market?
5. What factors are helping or slowing down the growth of the colon targeting drug delivery market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model